During the past decade, Ophthalmic Consultants of Boston conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ophthalmic Consultants of Boston" are "Keratoconus" (3 trials), "Cataract Surgery" (1 trials), "Corneal Ectasia" (1 trials), "Hyperopia" (1 trials) and "Hyperopic Astigmatism" (1 trials). Many other conditions were trialed in "Ophthalmic Consultants of Boston" in a lesser frequency.

Most popular intervention types in "Ophthalmic Consultants of Boston" are "Drug" (6 trials), "Device" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "KXL System" (2 trials), "placebo solution" (2 trials), "riboflavin solution" (2 trials), "KXL High Power System (10 J)" (1 trials) and "KXL High Power System (2 J)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ophthalmic Consultants of Boston" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Ophthalmic Consultants of Boston". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ophthalmic Consultants of Boston, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ophthalmic Consultants of Boston, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".